<?xml version="1.0" encoding="UTF-8"?>
<descriptions>
   <description count="1" length="3" conceptId="1" type="pref" language="en-US" superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">DTP</description>
   <description count="1" length="3" conceptId="10" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">IPV</description>
   <description count="2" length="22" conceptId="100" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">pneumococcal conjugate</description>
   <description count="2" length="14" conceptId="101" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">typhoid, ViCPs</description>
   <description count="1" length="9" conceptId="11" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">pertussis</description>
   <description count="2" length="20" conceptId="12" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">diphtheria antitoxin</description>
   <description count="1" length="3" conceptId="13" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">TIG</description>
   <description count="2" length="7" conceptId="14" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">IG, NOS</description>
   <description count="6" length="49" conceptId="15" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">influenza, split (incl. purified surface antigen)</description>
   <description count="2" length="16" conceptId="16" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">influenza, whole</description>
   <description count="2" length="8" conceptId="17" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Hib, NOS</description>
   <description count="3" length="31" conceptId="18" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">rabies, intramuscular injection</description>
   <description count="1" length="3" conceptId="19" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">BCG</description>
   <description count="1" length="3" conceptId="2" type="pref" language="en-US" superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">OPV</description>
   <description count="1" length="4" conceptId="20" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">DTaP</description>
   <description count="1" length="9" conceptId="21" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">varicella</description>
   <description count="1" length="7" conceptId="22" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">DTP-Hib</description>
   <description count="1" length="6" conceptId="23" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">plague</description>
   <description count="1" length="7" conceptId="24" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Anthrax</description>
   <description count="2" length="13" conceptId="25" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">typhoid, oral</description>
   <description count="1" length="7" conceptId="26" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Cholera</description>
   <description count="2" length="19" conceptId="27" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">botulinum antitoxin</description>
   <description count="2" length="14" conceptId="28" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">DT (pediatric)</description>
   <description count="1" length="5" conceptId="29" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">CMVIG</description>
   <description count="1" length="3" conceptId="3" type="pref" language="en-US" superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">MMR</description>
   <description count="1" length="4" conceptId="30" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">HBIG</description>
   <description count="4" length="21" conceptId="31" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Hep A, pediatric, NOS</description>
   <description count="1" length="13" conceptId="32" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">meningococcal</description>
   <description count="1" length="12" conceptId="33" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">pneumococcal</description>
   <description count="1" length="3" conceptId="34" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">RIG</description>
   <description count="2" length="14" conceptId="35" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">tetanus toxoid</description>
   <description count="1" length="4" conceptId="36" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">VZIG</description>
   <description count="2" length="12" conceptId="37" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">yellow fever</description>
   <description count="1" length="13" conceptId="38" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">rubella/mumps</description>
   <description count="2" length="21" conceptId="39" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Japanese encephalitis</description>
   <description count="1" length="3" conceptId="4" type="pref" language="en-US" superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">M/R</description>
   <description count="3" length="29" conceptId="40" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">rabies, intradermal injection</description>
   <description count="2" length="19" conceptId="41" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">typhoid, parenteral</description>
   <description count="5" length="34" conceptId="42" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Hep B, adolescent/high risk infant</description>
   <description count="3" length="12" conceptId="43" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Hep B, adult</description>
   <description count="3" length="15" conceptId="44" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Hep B, dialysis</description>
   <description count="3" length="10" conceptId="45" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Hep B, NOS</description>
   <description count="2" length="11" conceptId="46" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Hib (PRP-D)</description>
   <description count="2" length="10" conceptId="47" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Hib (HbOC)</description>
   <description count="2" length="11" conceptId="48" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Hib (PRP-T)</description>
   <description count="2" length="13" conceptId="49" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Hib (PRP-OMP)</description>
   <description count="1" length="7" conceptId="5" type="pref" language="en-US" superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">measles</description>
   <description count="1" length="7" conceptId="50" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">DTaPHib</description>
   <description count="2" length="9" conceptId="51" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Hib-Hep B</description>
   <description count="3" length="12" conceptId="52" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Hep A, adult</description>
   <description count="5" length="40" conceptId="53" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">typhoid, parenteral, AKD (U.S. military)</description>
   <description count="3" length="18" conceptId="54" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">adenovirus, type 4</description>
   <description count="3" length="18" conceptId="55" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">adenovirus, type 7</description>
   <description count="2" length="12" conceptId="56" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">dengue fever</description>
   <description count="1" length="10" conceptId="57" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Hantavirus</description>
   <description count="2" length="5" conceptId="58" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Hep C</description>
   <description count="2" length="5" conceptId="59" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Hep E</description>
   <description count="1" length="7" conceptId="6" type="pref" language="en-US" superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">rubella</description>
   <description count="3" length="16" conceptId="60" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">herpes simplex 2</description>
   <description count="1" length="3" conceptId="61" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">HIV</description>
   <description count="1" length="3" conceptId="62" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">HPV</description>
   <description count="2" length="11" conceptId="63" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Junin virus</description>
   <description count="1" length="13" conceptId="64" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">leishmaniasis</description>
   <description count="1" length="7" conceptId="65" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">leprosy</description>
   <description count="2" length="12" conceptId="66" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Lyme disease</description>
   <description count="1" length="7" conceptId="67" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">malaria</description>
   <description count="1" length="8" conceptId="68" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">melanoma</description>
   <description count="1" length="15" conceptId="69" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">parainfluenza-3</description>
   <description count="1" length="5" conceptId="7" type="pref" language="en-US" superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">mumps</description>
   <description count="2" length="7" conceptId="70" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Q fever</description>
   <description count="1" length="8" conceptId="71" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">RSV-IGIV</description>
   <description count="2" length="15" conceptId="72" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">rheumatic fever</description>
   <description count="3" length="17" conceptId="73" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Rift Valley fever</description>
   <description count="1" length="9" conceptId="74" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">rotavirus</description>
   <description count="1" length="8" conceptId="75" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">smallpox</description>
   <description count="3" length="30" conceptId="76" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Staphylococcus bacterio lysate</description>
   <description count="2" length="23" conceptId="77" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">tick-borne encephalitis</description>
   <description count="2" length="17" conceptId="78" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">tularemia vaccine</description>
   <description count="3" length="24" conceptId="79" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">vaccinia immune globulin</description>
   <description count="5" length="30" conceptId="8" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Hep B, adolescent or pediatric</description>
   <description count="2" length="9" conceptId="80" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">VEE, live</description>
   <description count="2" length="16" conceptId="81" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">VEE, inactivated</description>
   <description count="2" length="15" conceptId="82" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">adenovirus, NOS</description>
   <description count="5" length="23" conceptId="83" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Hep A, ped/adol, 2 dose</description>
   <description count="5" length="23" conceptId="84" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Hep A, ped/adol, 3 dose</description>
   <description count="3" length="10" conceptId="85" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Hep A, NOS</description>
   <description count="1" length="2" conceptId="86" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">IG</description>
   <description count="1" length="4" conceptId="87" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">IGIV</description>
   <description count="2" length="14" conceptId="88" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">influenza, NOS</description>
   <description count="2" length="10" conceptId="89" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">polio, NOS</description>
   <description count="2" length="10" conceptId="9" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">Td (adult)</description>
   <description count="2" length="11" conceptId="90" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">rabies, NOS</description>
   <description count="2" length="12" conceptId="91" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">typhoid, NOS</description>
   <description count="2" length="8" conceptId="92" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">VEE, NOS</description>
   <description count="1" length="7" conceptId="93" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">RSV-Mab</description>
   <description count="1" length="4" conceptId="94" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">MMRV</description>
   <description count="3" length="16" conceptId="95" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">TST-OT tine test</description>
   <description count="2" length="19" conceptId="96" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">TST-PPD intradermal</description>
   <description count="3" length="17" conceptId="97" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">TST-PPD tine test</description>
   <description count="2" length="8" conceptId="98" type="pref" language="en-US"
                superClasses=""
                classificationId="2.16.840.1.113883.5.145"
                classificationName="VaccineType">TST, NOS</description>
</descriptions>